Y-Intercept (HK)’s Organogenesis Holdings ORGO Stock Holding History

Y-Intercept (HK)’s Portfolio ORGO Stock Details ORGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-22,596	Closed	-$75K	–	1448
2023 Q2	$75K	Buy	+22,596	New	+$66.8K	0.01%	1153
2022 Q4	–	Sell	-24,401	Closed	-$79.1K	–	1255
2022 Q3	$79.1K	Sell	24,401 -7,918	-24%	-$35.8K	0.01%	895
2022 Q2	$158K	Buy	+32,319	New	+$199K	0.02%	699

Other funds holding ORGO

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Y-Intercept (HK)'s ORGO Position: Q3 2023 in Review

Y-Intercept (HK) sold out of Organogenesis Holdings (ORGO) in Q3 2023, closing a stake of 22,596 shares — an estimated $75K sold.

Y-Intercept (HK) first reported a position in ORGO in Q2 2022 and held it in 3 quarters. The position peaked at $158K in Q2 2022. 104 funds tracked by Wall St. Rank hold ORGO as of Q3 2023.

Y-Intercept (HK) reported no remaining Organogenesis Holdings position as of Q3 2023 after selling out during the quarter.
Y-Intercept (HK) sold 22,596 Organogenesis Holdings shares in Q3 2023, an estimated $75K.
Y-Intercept (HK) first reported a position in Organogenesis Holdings in Q2 2022 and held it in 3 quarters.
Y-Intercept (HK)'s Organogenesis Holdings position peaked at $158K in Q2 2022.
104 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q3 2023.

Based on Y-Intercept (HK)'s 13F filing for Q3 2023, filed 14 Nov 2023.